Anup Malani to Humans
This is a "connection" page, showing publications Anup Malani has written about Humans.
Connection Strength
0.195
-
Comparing population-level humoral and cellular immunity to SARS-Cov-2 in Bangalore, India. Sci Rep. 2024 03 08; 14(1):5758.
Score: 0.032
-
Conceptual and analytical approaches for modelling the developmental origins of inequality. Philos Trans R Soc Lond B Biol Sci. 2023 08 14; 378(1883):20220306.
Score: 0.031
-
Representative estimates of COVID-19 infection fatality rates from four locations in India: cross-sectional study. BMJ Open. 2021 10 05; 11(10):e050920.
Score: 0.027
-
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India. Lancet Glob Health. 2021 02; 9(2):e110-e111.
Score: 0.026
-
Advertisements impact the physiological efficacy of a branded drug. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):12931-5.
Score: 0.015
-
Accounting for heterogeneous treatment effects in the FDA approval process. Food Drug Law J. 2012; 67(1):23-50, i.
Score: 0.014
-
Regulation with placebo effects. Duke Law J. 2008 Dec; 58(3):411-72..
Score: 0.011
-
Expectations mediate objective physiological placebo effects. Adv Health Econ Health Serv Res. 2008; 20:311-27.
Score: 0.010
-
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India. Sci Rep. 2024 01 24; 14(1):2091.
Score: 0.008
-
Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India. Med. 2023 03 10; 4(3):182-190.e3.
Score: 0.007
-
Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India. Nat Med. 2022 05; 28(5):934-938.
Score: 0.007
-
Prevalence of SARS-CoV-2 in Karnataka, India. JAMA. 2021 03 09; 325(10):1001-1003.
Score: 0.007